IM Cannabis (IMCC) Receivables (2019 - 2026)

IM Cannabis' Receivables history runs 8 years deep, the most recent figure standing at $5.2 million for Q1 2026.

• In Q1 2026, Receivables changed N/A year-over-year to $5.2 million; the TTM figure through Mar 2026 stood at $5.2 million (changed N/A YoY), while the FY2025 annual figure was $7.9 million, down 22.86% from the prior year.
• Receivables was $5.2 million for Q1 2026 at IM Cannabis, down from $7.9 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $24.2 million in Q1 2022 to a low of $5.2 million in Q1 2026.
• Historically, Receivables has averaged $10.4 million across 5 years, with a median of $9.0 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Receivables tumbled 69.8% in 2023, then surged 59.69% in 2024.
• A 5-year view of Receivables shows it stood at $6.5 million in 2022, then fell by 3.52% to $6.3 million in 2023, then soared by 59.69% to $10.1 million in 2024, then fell by 21.29% to $7.9 million in 2025, then plunged by 34.12% to $5.2 million in 2026.
• The last three Receivables figures came in at $5.2 million (Q1 2026), $7.9 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.